Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ImmunityBio Inc. Common Stock (IBRX) vs Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) Price & Performance

ImmunityBio Inc. Common StockTrade
Mizuho Financial Group Inc. Sponosred ADR (Japan)Trade

Price performance (Past 24H)

Key statistics

ImmunityBio Inc. Common Stock vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.58 (market cap $132.18B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 12.8× ImmunityBio Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.

IBRXMFG
Market Cap
$10.33B$132.18B
Volume
11,745,1983,264,662
Sector
HealthFinancials
52-Week High
$11.55$11.45
52-Week Low
$1.98$6.09
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.79B$35.48T
Dividend Yield
—1.7%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBRX
100% Buy0% Sell
Avg holding period · 0 Days
MFG
100% Buy0% Sell
Avg holding period · 0 Days

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →

About Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.

Read more on MFG →